ATAD2 and ovarian cancer: Collectively, our studies illuminate the role of ATAD2 as a facilitator of ovarian cancer growth and metastasis and indicate that ATAD2 inhibitors, used either alone or in combination with CENPE inhibitors, may represent therapeutic option for treating ovarian cancer patients.